Seoul, South Korea

Woo Ick Jang


 

 

Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Woo Ick Jang

Introduction: Woo Ick Jang is a prominent inventor based in Seoul, South Korea, known for his significant contributions to the pharmaceutical industry. With a total of two patents to his name, he has played an essential role in developing treatments for growth hormone deficiency and various autoimmune diseases.

Latest Patents: Woo Ick Jang's latest patents include groundbreaking advancements in pharmaceutical compositions. One patent focuses on a pharmaceutical composition that comprises recombinant human growth hormone (hGH) for treating growth hormone deficiency. This innovative method allows for the administration of recombinant human growth hormone GX-H9 on a weekly or bi-monthly basis, tailored to the patient's weight.

Another patent showcases a human interleukin-1 receptor antagonist hybrid Fc fusion protein. This disclosure presents a fusion protein that combines IL-1 receptor antagonist with a hybrid Fc region, intended for treating autoimmune diseases including rheumatoid arthritis, inflammatory bowel disease, psoriasis, and diabetes. The design of this fusion protein aims to provide excellent efficacy and reduced side effects, making it a strong candidate for clinical development as a therapeutic antibody.

Career Highlights: Throughout his career, Woo Ick Jang has established himself within the pharmaceutical sector, contributing to leading companies such as Genexine, Inc. and Handok Pharmaceuticals, Inc. His work has made a substantial impact in the development of innovative treatments that address significant health challenges.

Collaborations: Woo Ick Jang has had the opportunity to collaborate with notable colleagues in the field, including Young Gyu Cho and Hye Jeong Shin. These collaborations have allowed for sharing of knowledge and expertise, further enhancing the innovation process in their projects.

Conclusion: Inventor Woo Ick Jang has made remarkable contributions to the pharmaceutical landscape through his patents and collaborative efforts. His innovations in treating growth hormone deficiency and autoimmune diseases reflect his dedication to improving patient care and advancing medical science. As he continues to explore new avenues for research and development, his impact is sure to resonate in the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…